What's breaking now, across thousands of outlets.
(MedPage Today) -- Overall survival (OS) in heavily pretreated gastroesophageal carcinoma (GEC) doubled in patients who received an investigational antibody-drug conjugate (ADC) targeting claudin (CLDN) 18.2, a randomized trial showed. Patients...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
WASHINGTON (AP) — A plan to give Americans easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr.
Dr Ato Kwamena Sagoe, a former Ghana Secondary Technical School (GSTS) student who represented the school at the 2005 National Science and Maths Quiz (NSMQ), has died in the United Kingdom following a…
The highest dose of retatrutide beat Ozempic on measures of blood sugar and weight loss, but was also associated with higher side effect rates and treatment discontinuations.
Adults with borderline personality disorder who ate more foods high in fat and sugar tended to be more impulsive and took more risks on a gambling task, though their diets were unrelated to overall…
Apertura says widening access to its TfR1 CapX capsid is a core philosophy, and that includes inviting a wide range of collaborations and supporting collaborators through advice and preclinical…
Most microbes remain out of reach, and many antibiotic-producing genes stay silent. A new review argues that combining genomics, innovative cultivation, and scalable manufacturing could turn this…
